Furthermore, GSK is well known for providing its brand products with a price in Egypt that can be a fraction of its regular price in the region. Of the top 20 multinational corporations working in ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

GSK, formerly known as GlaxoSmithKline, continues to distinguish itself through its vast array of medicines, vaccines and consumer health care products ... the overall well-being of individuals ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

As a leading developer of vaccines, GSK has a part to play in this, with experts who are well positioned to provide ... Administration in the US). A little known but important fact about vaccines ...

The financial information company S&P Global, most known for the S ... in COVID-19 related products in recent years has ...

as well new oral care products that address a range of people’s needs, including prevention of early periodontal disease (gingivitis) and reduction in tooth sensitivity. GSK Consumer Healthcare ...

Nevertheless, Haleon is a great stock for the current environment we’re in. The resilience of its brands is fueling investors’ interest in HLN — as are fears about a slowing U.S. economy and ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

Vaccines have started to trickle into the Democratic Republic of Congo after a lethal mpox outbreak, but it’s nowhere near ...